3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Sell
43
CLBT Quote, Financials, Valuation and Earnings
Last price:
$19.80
Seasonality move
:
15.21%
Day range:
$19.16 - $19.91
52-week range:
$10.25 - $26.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.36x
P/B ratio:
14.14x
Volume:
913K
Avg. volume:
943.1K
1-year change:
76.04%
Market cap:
$4.8B
Revenue:
$401.2M
EPS (TTM):
-$1.39
Earnings Data
Next earnings date for CLBT
May 14
2025
Most recent earnings per share
$0.08
Missed by $0.02
(Feb 13/2025)
Consensus Estimate
$0.10
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CLBT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $115.3M | -- | -- | $0.10 | -- |
| 05/14/2025 | Q1 | $109.4M | -- | -- | $0.09 | -- |
| 02/13/2025 | Q4 | $107.1M | $109M | $0.08 | $0.10 | -$0.02 |
| 11/06/2024 | Q3 | $102.1M | $106.9M | -$0.99 | $0.09 | -$1.08 |
| 08/15/2024 | Q2 | $91.9M | $95.7M | -$0.12 | $0.05 | -$0.17 |
| 05/23/2024 | Q1 | $85.4M | $89.6M | -$0.36 | $0.06 | -$0.42 |
| 02/15/2024 | Q4 | $85.5M | $93M | -$0.08 | $0.06 | -$0.14 |
| 11/14/2023 | Q3 | $82.1M | $84.2M | $0.03 | $0.05 | -$0.02 |
| 08/08/2023 | Q2 | $72.5M | $76.7M | -$0.17 | $0.02 | -$0.19 |
| 05/10/2023 | Q1 | $69.4M | $71.2M | -$0.21 | $0.02 | -$0.23 |
| 02/15/2023 | Q4 | -- | $74M | $0.04 | -- | -- |
| 11/17/2022 | Q3 | -- | $71.7M | $0.13 | -- | -- |
| 08/11/2022 | Q2 | -- | $62.6M | $0.17 | -- | -- |
| 05/12/2022 | Q1 | -- | $62.4M | $0.27 | -- | -- |
| 02/16/2022 | Q4 | -- | $67.9M | $0.25 | -- | -- |
| 11/10/2021 | Q3 | -- | $65.9M | $0.05 | -- | -- |
| 06/30/2021 | Q2 | -- | $59.2M | $0.04 | -- | -- |
| 03/31/2021 | Q1 | -- | $53.3M | $0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | $57.2M | -$0.07 | -- | -- |
| 09/30/2020 | Q3 | -- | $53.2M | $0.04 | -- | -- |
| 06/30/2020 | Q2 | -- | $45.8M | -$0.01 | -- | -- |
Cellebrite DI Earnings Questions
-
How Much did Cellebrite DI Generate in Revenue Last Quarter?
Cellebrite DI reported $109M worth of top line sales in its most recent quarter.
-
Did Cellebrite DI Beat Earnings Last Quarter?
Cellebrite DI announced earnings per share of $0.08 which represents a miss of analyst forecast a $0.10 per share.
-
Is Cellebrite DI Profitable?
Cellebrite DI reported $91.4M that represents $0.39 per share over the last quarter.
-
What is the Analyst Consensus for Cellebrite DI EPS Next Year?
Cellebrite DI's earnings are forecast to decrease from -$1.35 per share to $0.43 per share next year representing a decrease of -57.41%.
-
When is Cellebrite DI's Earnings Date?
Cellebrite DI's next earnings date is May 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
